Cargando…

Associations with antibiotic prescribing for acute exacerbation of COPD in primary care: secondary analysis of a randomised controlled trial

BACKGROUND: C-reactive protein (CRP) point-of-care testing can reduce antibiotic use in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in primary care, without compromising patient care. Further safe reductions may be possible. AIM: To investigate the associations...

Descripción completa

Detalles Bibliográficos
Autores principales: Gillespie, David, Butler, Christopher C, Bates, Janine, Hood, Kerenza, Melbye, Hasse, Phillips, Rhiannon, Stanton, Helen, Alam, Mohammed Fasihul, Cals, Jochen WL, Cochrane, Ann, Kirby, Nigel, Llor, Carl, Lowe, Rachel, Naik, Gurudutt, Riga, Evgenia, Sewell, Bernadette, Thomas-Jones, Emma, White, Patrick, Francis, Nick A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal College of General Practitioners 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007268/
https://www.ncbi.nlm.nih.gov/pubmed/33657007
http://dx.doi.org/10.3399/BJGP.2020.0823
_version_ 1783672453455675392
author Gillespie, David
Butler, Christopher C
Bates, Janine
Hood, Kerenza
Melbye, Hasse
Phillips, Rhiannon
Stanton, Helen
Alam, Mohammed Fasihul
Cals, Jochen WL
Cochrane, Ann
Kirby, Nigel
Llor, Carl
Lowe, Rachel
Naik, Gurudutt
Riga, Evgenia
Sewell, Bernadette
Thomas-Jones, Emma
White, Patrick
Francis, Nick A
author_facet Gillespie, David
Butler, Christopher C
Bates, Janine
Hood, Kerenza
Melbye, Hasse
Phillips, Rhiannon
Stanton, Helen
Alam, Mohammed Fasihul
Cals, Jochen WL
Cochrane, Ann
Kirby, Nigel
Llor, Carl
Lowe, Rachel
Naik, Gurudutt
Riga, Evgenia
Sewell, Bernadette
Thomas-Jones, Emma
White, Patrick
Francis, Nick A
author_sort Gillespie, David
collection PubMed
description BACKGROUND: C-reactive protein (CRP) point-of-care testing can reduce antibiotic use in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in primary care, without compromising patient care. Further safe reductions may be possible. AIM: To investigate the associations between presenting features and antibiotic prescribing in patients with AECOPD in primary care. DESIGN AND SETTING: Secondary analysis of a randomised controlled trial of participants presenting with AECOPD in primary care (the PACE trial). METHOD: Clinicians collected participants’ demographic features, comorbid illnesses, clinical signs, and symptoms. Antibiotic prescribing decisions were made after participants were randomised to receive a point-of-care CRP measurement or usual care. Multivariable regression models were fitted to explore the association between patient and clinical features and antibiotic prescribing, and extended to further explore any interactions with CRP measurement category (CRP not measured, CRP <20 mg/l, or CRP ≥20 mg/l). RESULTS: A total of 649 participants from 86 general practices across England and Wales were included. Odds of antibiotic prescribing were higher in the presence of clinician-recorded crackles (adjusted odds ratio [AOR] = 5.22, 95% confidence interval [CI] = 3.24 to 8.41), wheeze (AOR = 1.64, 95% CI = 1.07 to 2.52), diminished vesicular breathing (AOR = 2.95, 95% CI = 1.70 to 5.10), or clinician-reported evidence of consolidation (AOR = 34.40, 95% CI = 2.84 to 417.27). Increased age was associated with lower odds of antibiotic prescribing (AOR per additional year increase = 0.98, 95% CI = 0.95 to 1.00), as was the presence of heart failure (AOR = 0.32, 95% CI = 0.12 to 0.85). CONCLUSION: Several demographic features and clinical signs and symptoms are associated with antibiotic prescribing in AECOPD. Diagnostic and prognostic value of these features may help identify further safe reductions.
format Online
Article
Text
id pubmed-8007268
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Royal College of General Practitioners
record_format MEDLINE/PubMed
spelling pubmed-80072682021-04-01 Associations with antibiotic prescribing for acute exacerbation of COPD in primary care: secondary analysis of a randomised controlled trial Gillespie, David Butler, Christopher C Bates, Janine Hood, Kerenza Melbye, Hasse Phillips, Rhiannon Stanton, Helen Alam, Mohammed Fasihul Cals, Jochen WL Cochrane, Ann Kirby, Nigel Llor, Carl Lowe, Rachel Naik, Gurudutt Riga, Evgenia Sewell, Bernadette Thomas-Jones, Emma White, Patrick Francis, Nick A Br J Gen Pract Research BACKGROUND: C-reactive protein (CRP) point-of-care testing can reduce antibiotic use in patients with acute exacerbation of chronic obstructive pulmonary disease (AECOPD) in primary care, without compromising patient care. Further safe reductions may be possible. AIM: To investigate the associations between presenting features and antibiotic prescribing in patients with AECOPD in primary care. DESIGN AND SETTING: Secondary analysis of a randomised controlled trial of participants presenting with AECOPD in primary care (the PACE trial). METHOD: Clinicians collected participants’ demographic features, comorbid illnesses, clinical signs, and symptoms. Antibiotic prescribing decisions were made after participants were randomised to receive a point-of-care CRP measurement or usual care. Multivariable regression models were fitted to explore the association between patient and clinical features and antibiotic prescribing, and extended to further explore any interactions with CRP measurement category (CRP not measured, CRP <20 mg/l, or CRP ≥20 mg/l). RESULTS: A total of 649 participants from 86 general practices across England and Wales were included. Odds of antibiotic prescribing were higher in the presence of clinician-recorded crackles (adjusted odds ratio [AOR] = 5.22, 95% confidence interval [CI] = 3.24 to 8.41), wheeze (AOR = 1.64, 95% CI = 1.07 to 2.52), diminished vesicular breathing (AOR = 2.95, 95% CI = 1.70 to 5.10), or clinician-reported evidence of consolidation (AOR = 34.40, 95% CI = 2.84 to 417.27). Increased age was associated with lower odds of antibiotic prescribing (AOR per additional year increase = 0.98, 95% CI = 0.95 to 1.00), as was the presence of heart failure (AOR = 0.32, 95% CI = 0.12 to 0.85). CONCLUSION: Several demographic features and clinical signs and symptoms are associated with antibiotic prescribing in AECOPD. Diagnostic and prognostic value of these features may help identify further safe reductions. Royal College of General Practitioners 2021-03-09 /pmc/articles/PMC8007268/ /pubmed/33657007 http://dx.doi.org/10.3399/BJGP.2020.0823 Text en © The Authors http://creativecommons.org/licenses/by/4.0/ http://creativecommons.org/licenses/by/4.0/This article is Open Access: CC BY 4.0 licence (http://creativecommons.org/licences/by/4.0/).
spellingShingle Research
Gillespie, David
Butler, Christopher C
Bates, Janine
Hood, Kerenza
Melbye, Hasse
Phillips, Rhiannon
Stanton, Helen
Alam, Mohammed Fasihul
Cals, Jochen WL
Cochrane, Ann
Kirby, Nigel
Llor, Carl
Lowe, Rachel
Naik, Gurudutt
Riga, Evgenia
Sewell, Bernadette
Thomas-Jones, Emma
White, Patrick
Francis, Nick A
Associations with antibiotic prescribing for acute exacerbation of COPD in primary care: secondary analysis of a randomised controlled trial
title Associations with antibiotic prescribing for acute exacerbation of COPD in primary care: secondary analysis of a randomised controlled trial
title_full Associations with antibiotic prescribing for acute exacerbation of COPD in primary care: secondary analysis of a randomised controlled trial
title_fullStr Associations with antibiotic prescribing for acute exacerbation of COPD in primary care: secondary analysis of a randomised controlled trial
title_full_unstemmed Associations with antibiotic prescribing for acute exacerbation of COPD in primary care: secondary analysis of a randomised controlled trial
title_short Associations with antibiotic prescribing for acute exacerbation of COPD in primary care: secondary analysis of a randomised controlled trial
title_sort associations with antibiotic prescribing for acute exacerbation of copd in primary care: secondary analysis of a randomised controlled trial
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007268/
https://www.ncbi.nlm.nih.gov/pubmed/33657007
http://dx.doi.org/10.3399/BJGP.2020.0823
work_keys_str_mv AT gillespiedavid associationswithantibioticprescribingforacuteexacerbationofcopdinprimarycaresecondaryanalysisofarandomisedcontrolledtrial
AT butlerchristopherc associationswithantibioticprescribingforacuteexacerbationofcopdinprimarycaresecondaryanalysisofarandomisedcontrolledtrial
AT batesjanine associationswithantibioticprescribingforacuteexacerbationofcopdinprimarycaresecondaryanalysisofarandomisedcontrolledtrial
AT hoodkerenza associationswithantibioticprescribingforacuteexacerbationofcopdinprimarycaresecondaryanalysisofarandomisedcontrolledtrial
AT melbyehasse associationswithantibioticprescribingforacuteexacerbationofcopdinprimarycaresecondaryanalysisofarandomisedcontrolledtrial
AT phillipsrhiannon associationswithantibioticprescribingforacuteexacerbationofcopdinprimarycaresecondaryanalysisofarandomisedcontrolledtrial
AT stantonhelen associationswithantibioticprescribingforacuteexacerbationofcopdinprimarycaresecondaryanalysisofarandomisedcontrolledtrial
AT alammohammedfasihul associationswithantibioticprescribingforacuteexacerbationofcopdinprimarycaresecondaryanalysisofarandomisedcontrolledtrial
AT calsjochenwl associationswithantibioticprescribingforacuteexacerbationofcopdinprimarycaresecondaryanalysisofarandomisedcontrolledtrial
AT cochraneann associationswithantibioticprescribingforacuteexacerbationofcopdinprimarycaresecondaryanalysisofarandomisedcontrolledtrial
AT kirbynigel associationswithantibioticprescribingforacuteexacerbationofcopdinprimarycaresecondaryanalysisofarandomisedcontrolledtrial
AT llorcarl associationswithantibioticprescribingforacuteexacerbationofcopdinprimarycaresecondaryanalysisofarandomisedcontrolledtrial
AT lowerachel associationswithantibioticprescribingforacuteexacerbationofcopdinprimarycaresecondaryanalysisofarandomisedcontrolledtrial
AT naikgurudutt associationswithantibioticprescribingforacuteexacerbationofcopdinprimarycaresecondaryanalysisofarandomisedcontrolledtrial
AT rigaevgenia associationswithantibioticprescribingforacuteexacerbationofcopdinprimarycaresecondaryanalysisofarandomisedcontrolledtrial
AT sewellbernadette associationswithantibioticprescribingforacuteexacerbationofcopdinprimarycaresecondaryanalysisofarandomisedcontrolledtrial
AT thomasjonesemma associationswithantibioticprescribingforacuteexacerbationofcopdinprimarycaresecondaryanalysisofarandomisedcontrolledtrial
AT whitepatrick associationswithantibioticprescribingforacuteexacerbationofcopdinprimarycaresecondaryanalysisofarandomisedcontrolledtrial
AT francisnicka associationswithantibioticprescribingforacuteexacerbationofcopdinprimarycaresecondaryanalysisofarandomisedcontrolledtrial